Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Akebia Therapeutics, Inc. (AKBA) had Receiveable Turnover of 4.95 for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$194.62M |
|
$-51.92M |
|
$74.15M |
|
$120.47M |
|
$240.88M |
|
$-46.26M |
|
$-5.67M |
|
$-51.92M |
|
$-51.92M |
|
$-51.92M |
|
$-51.92M |
|
$-51.92M |
|
$-51.92M |
|
$-46.26M |
|
$-8.63M |
|
187.47M |
|
187.47M |
|
$-0.28 |
|
$-0.28 |
|
Balance Sheet Financials | |
$118.15M |
|
$3.63M |
|
$123.55M |
|
$241.70M |
|
$99.87M |
|
$17.18M |
|
$172.42M |
|
$272.29M |
|
$-30.58M |
|
$-125.67M |
|
$-30.58M |
|
194.58M |
|
Cash Flow Statement Financials | |
$-23.38M |
|
$0.00M |
|
$-25.21M |
|
$93.17M |
|
$44.58M |
|
$-48.59M |
|
$9.32M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.18 |
|
-- |
|
-- |
|
-1.28 |
|
-1.13 |
|
61.90% |
|
-23.77% |
|
-23.77% |
|
-4.43% |
|
-26.68% |
|
-26.68% |
|
$-23.38M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
4.73 |
|
Receiveable Turnover |
4.95 |
73.69 |
|
169.78% |
|
41.32% |
|
-21.48% |
|
387.47% |
|
$-0.16 |
|
$-0.12 |
|
$-0.12 |